The major factors attributing to the growth of the market are the rise in the global prevalence of Infectious diseases with decreased immunity and increased antibiotic resistance along with a steep rise in communicable diseases demanding the diagnosis. For instance, according to a UNAIDS report, in 2018, about approximately 37.9 million people were living with HIV globally which is estimated to be continued throughout the forecast period.
Also, increased adoption of western blot as the standard test in the detection of anti-HIV antibodies in blood serum samples and to confirm them is one of the factors fueling of western blotting processors and fuel the demand for western blotting processors globally.
Key Market Trends
Automated Dry Blotting Systems in Products Segment are Expected to Hold the Major Market Share
The Automated dry blotting systems have dominated the industry in recent years and is expected to witness lucrative growth over the forecast period. The dominance is due to their ability to analyze several samples in a single trial reducing the processing time and the complete automation avoids all the manual tasks except sample loading into the western blotting system.
Based on the application, medical diagnostics account for the largest market share due to a rise in increasing incidences of target diseases such as Lyme disease, and Hepatitis across the globe. Also, the use of these devices to detect specific protein molecules from a complex mixture of protein samples in proteomics and genetic science is expected to drive the market growth in the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the global western blotting processors market throughout the forecast period. This dominance is mainly owing to the availability of advanced healthcare infrastructure, rapid diagnostic treatment using western blotting processors and increased incidences of HIV, BSE, FIV, and hepatitis B infections in the United States. For instance, according to the Joint United Nations Programme on HIV and AIDS (UNAIDS), 24.5 million people received antiretroviral therapy in 2019 which is estimated to increase in the forecast period and drive the global market.
And, Europe holds the second-largest revenue share of the market and expected to do the same in the forecast period due to increased healthcare expenditure and favorable reimbursement policies by the government for disease diagnosis along with a rise in infectious diseases. Also, the presence of a few manufacturers and growing R&D investments by key players in the region to launch novel devices to address the current issues with processors and outstand in the rising competition among the key players are driving the market.
The global western blotting processors market is moderately competitive and consists of several major players. Some prominent players that are currently dominating the market in terms of revenue are implementing various strategies such as launching new products, making acquisitions or entering partnerships and expanding their production capacities to strengthen their position in the global market. Early product launches with the quick approvals due to enhanced features are expected to create an active competition in the global western blotting processors market.
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Study Assumptions
1.3 Scope of the Study
4.2 Market Drivers
4.2.1 Rise in Global Prevalence of HIV/AIDS and LYME Diseases
4.2.2 Increasing Demand for Automation of the Diagnosis and Analysis
4.3 Market Restraints
4.3.1 High cost of Labor and Automated Western Blotting Processors
4.3.2 Necessity to Update Regularly to Avoid Inconsistent and Skewed Results
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Automated Dry Blotting Systems
5.1.2 Semi-Dry Blotting Systems
5.1.3 Traditional Wet Transfer Blotting Systems
5.2 By Application
5.2.1 Medical Diagnostics
5.2.2 Agricultural Application
5.3 By End-user
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 Academic and Research Institutes
5.4.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle-East and Africa
5.4.5 South America
220.127.116.11 Rest of South America
6.1.1 Analytik Jena AG
6.1.2 Cytoskeleton Inc
6.1.3 Bee Robotics Ltd
6.1.4 Bio-Rad Laboratories, Inc.
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 GE Healthcare
6.1.7 Protein Simple Inc. (Bio-Techne)
6.1.8 PerkinElmer Inc.
6.1.9 Expedeon AG
6.1.10 Merck KGaA
A selection of companies mentioned in this report includes:
- Analytik Jena AG
- Cytoskeleton Inc
- Bee Robotics Ltd
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- GE Healthcare
- Protein Simple Inc. (Bio-Techne)
- PerkinElmer Inc.
- Expedeon AG
- Merck KGaA